The pathogenesis and diagnosis of acute kidney injury in multiple myeloma-Reference-Cited by-同舟云学术

The pathogenesis and diagnosis of acute kidney injury in multiple myeloma

Published:2011-11-01 Issue:1 Volume:8 Page:43-51
ISSN:1759-5061
Container-title:Nature Reviews Nephrology
language:en
Short-container-title:Nat Rev Nephrol

Author:

Hutchison Colin A., ,Batuman Vecihi,Behrens Judith,Bridoux Frank,Sirac Christophe,Dispenzieri Angela,Herrera Guillermo A.,Lachmann Helen,Sanders Paul W.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://www.nature.com/articles/nrneph.2011.168.pdf

Reference107 articles.

1. Peto, R. Factors of prognostic significance in myelomatosis. J. Clin. Pathol. 25, 555 (1972).

2. Haynes, R. J., Read, S., Collins, G. P., Darby, S. C. & Winearls, C. G. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrol. Dial. Transplant. 25, 419–426 (2010).

3. Bladé, J. et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch. Intern. Med. 158, 1889–1893 (1998).

4. Leung, N. et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 73, 1282–1288 (2008).

5. Hutchison, C. A. et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin. J. Am. Soc. Nephrol. 4, 745–754 (2009).

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long journey on the role of long non-coding RNA (lncRNA) in acute kidney injury (AKI);Pathology - Research and Practice;2024-09

2. Features that characterize monoclonal light chain (“myeloma”) cast nephropathy with immunofluorescence challenges and emphasis on electron microscopy;Ultrastructural Pathology;2024-08-21

3. Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment—An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse;Clinical Lymphoma Myeloma and Leukemia;2024-08

4. The Monoclonal Gammopathies of Renal Significance;Acta Medica Martiniana;2024-08-01

5. Long-term Evolution of Hypophosphatemia and Osteomalacia in a Patient With Multiple Myeloma;JCEM Case Reports;2024-06-27